Unlocking Insights: Pulmonary Arterial Hypertension Market Trends and Analysis
October 9, 2023 ⚊ 1 Min read ⚊ Views 62 ⚊ BUSINESS
Dive into the dynamic landscape of the Pulmonary Arterial Hypertension (PAH) market. Gain valuable insights into emerging therapies, key players, and market dynamics driving advancements in PAH treatment and care. The key classes of drugs in the PAH market are Endothelin Receptor Antagonists, PDE5 Inhibitors, sGC Stimulator, Prostacyclin Receptor Agonists, BMP 10 Inhibitor, Tyrosine Kinase Inhibitor, and Nitric-Oxide Synthase Endothelial Activator. Endothelin Receptor Antagonists led the US PAH market.
Tags: Pulmonary, Pulmonary Arterial Hypertension Market
